Justin Darrah MD

Dr. Justin Darrah is a co-director of the Lymphoma Program and director of the CAR T-cell Therapy program at Cedars-Sinai. His clinical care focuses on all modalities of lymphoma treatment, including standard of care chemo/immunotherapy, CAR T-cell therapy, and stem cell transplant. He is the principal investigator on numerous clinical trials evaluating novel treatments for lymphoma. He helped create the first-ever Lymphoma Program at Cedars-Sinai, which provides comprehensive and coordinated care for lymphoma patients from diagnosis through late-line therapies, including stem cell transplant, CAR T-cell therapy, and clinical trials. He also led the CAR T-cell therapy program, which offers all commercially available CAR T-cell therapy products as well as several novel investigational products.